Selective role of sterol regulatory element binding protein isoforms in aggregated LDL-induced vascular low density lipoprotein receptor-related protein-1 expression

Atherosclerosis

Volumn 213, Issue 2, 2010, Pages 458-468

  Costales, P ^a   Aledo, R ^a,f   Vernia S ^b   Das, A ^c   Shah, V H ^d   Casado, M ^b,e   Badimon, L ^a,f   Llorente Cortes V ^a  

^a CSIC   (Spain)

^b INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

^c LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MAYO CLINIC   (United States)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f Instituto de Salud Carlos III   (Spain)

Author keywords

Aggregated LDL; Human VSMC; LRP1; SREBP 1a; SREBP 1c; SREBP 2

Indexed keywords

ISOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; SMALL INTERFERING RNA; STEROL REGULATORY ELEMENT BINDING PROTEIN;

ARTICLE; BLOOD SAMPLING; CHROMATIN IMMUNOPRECIPITATION; CORONARY ARTERY; EXPRESSION VECTOR; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; MUTANT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; RNA ISOLATION; SEQUENCE ANALYSIS; TRANSCRIPTION INITIATION; UPREGULATION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

DOWN-REGULATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HELA CELLS; HUMANS; LDL-RECEPTOR RELATED PROTEIN 1; LIPOPROTEINS, LDL; MUSCLE, SMOOTH, VASCULAR; PROTEIN ISOFORMS; RNA, MESSENGER; RNA, SMALL INTERFERING; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; STEROL REGULATORY ELEMENT BINDING PROTEINS; UP-REGULATION;

EID: 78649738130     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.09.034     Document Type: Article

References (45)

1. Schwartz S., Virmani R., Rosenfeld M.E. The good smooth muscle cells in atherosclerosis. Curr Atherosc Rep 2000, 2:422-429.
2. Plasschaert H., Heeneman S., Daemen M.J. Top Magn Reson Imag 2009, 20:227-237.
3. Oörni K., Posio P., Ala-Korpela M., Jauhiainen M., Kovanen P.T. Sphingomyelinase induces aggregation and fusion of small very low-density lipoprotein and intermediate-density lipoprotein particles and increases their retention to human arterial proteoglycans. Arterioscler Thromb Vasc Biol 2005, 25:1678-1683.
4. Hakala J.K., Oörni K., Pentikäinen M.O., Hurt-Camejo E., Kovanen P.T. Lipolysis of LDL by human secretory phospholipase A(2) induces particle fusion and enhances the retention of LDL to human aortic proteoglycans. Arterioscler Thromb Vasc Biol 2001, 21:1053-1058.
5. Llorente-Cortés V., Otero-Viñas M., Badimon L. Differential role of heparan sulfate proteoglycans on aggregated LDL uptake in human vascular smooth muscle cells and mouse embryonic fibroblasts. Arterioscler Thromb Vasc Biol 2002, 22:1905-1911.
6. Llorente-Cortés V., Otero-Viñas M., Hurt-Camejo E., Martínez-González J., Badimon L. Human coronary smooth muscle cells internalize versican-modified LDL through LDL receptor-related protein and LDL receptors. Arterioscler Thromb Vasc Biol 2002, 22:387-393.
7. Llorente-Cortés V., Martínez-González J., Badimon L. LDL receptor-related protein mediates uptake of aggregated LDL in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2000, 20:1572-1579.
8. Llorente-Cortés V., Otero-Viñas M., Sánchez S., Rodríguez C., Badimon L. Low-density lipoprotein upregulates low-density lipoprotein receptor-related protein expression in vascular smooth muscle cells: possible involvement of sterol regulatory element binding protein-2-dependent mechanism. Circulation 2002, 106:3104-3110.
9. Hiltunen T.P., Luoma J.S., Nikkari T., Yla-Herttuala S. Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development. Circulation 1998, 97:1079-1086.
10. Moestrup S.K., Gliemann J., Pallesen G. Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res 1992, 269:375-382.
11. Luoma J., Hiltunen T., Särkioja T., et al. Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions. J Clin Invest 1994, 93:2014-2021.
12. Llorente-Cortés V., Otero-Viñas M., Berrozpe M., Badimon L. Intracellular lipid accumulation, low-density lipoprotein receptor-related protein expression, and cell survival in vascular smooth muscle cells derived from normal and atherosclerotic human coronaries. Eur J Clin Invest 2004, 34:182-190.
13. Boucher P., Liu P., Gotthardt M., Hiesberger T., Anderson R.G., Herz J. Platelet-derived growth factor mediates tyrosine phosphorylation of the cytoplasmic domain of the low density lipoprotein receptor-related protein in caveolae. J Biol Chem 2002, 277:15507-15513.
14. Loukinova E., Ranganathan S., Kuznetsov S., et al. Platelet-derived growth factor (PDGF)-induced tyrosine phosphorylation of the low density lipoprotein receptor-related protein (LRP). Evidence for integrated co-receptor function betwen LRP and the PDGF. J Biol Chem 2002, 277:15499-15506.
15. Boucher P., Gotthardt M., Li W.P., Anderson R.G., Herz J. LRP: role in vascular wall integrity and protection from atherosclerosis. Science 2003, 300:329-332.
16. Llorente-Cortés V., Costales P., Bernués J., Camino-Lopez S., Badimon L. Sterol regulatory element-binding protein-2 negatively regulates low density lipoprotein receptor-related protein transcription. J Mol Biol 2006, 359:950-960.
17. Rodríguez C., Martínez-González J., Sánchez-Gómez S., Badimon L. LDL downregulates CYP51 in porcine vascular endothelial cells and in the arterial wall through a sterol regulatory element binding protein-2-dependent mechanism. Circ Res 2001, 88:268-274.
18. Yoshikawa T., Shimano H., Amemiya-Kudo M., et al. Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter. Moll Cell Biol 2001, 21:2991-3000.
19. Willy P.J., Umesono K., Ong E.S., Evans R.M., Heyman R.A., Mangelsdorf D.J. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 1995, 9:1033-1045.
20. Schultz J.R., Tu H., Luk A., et al. Role of LXRs in control of lipogenesis. Genes Dev 2000, 14:2831-2838.
21. Repa J.J., Liang G., Ou J., et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev 2000, 14:2819-2830.
22. Shimomura I., Bashmakov Y., Shimano H., Horton J.D., Goldstein J.L., Brown M.S. Cholesterol feeding reduces nuclear forms of sterol regulatory element binding proteins in hamster liver. Proc Natl Acad Sci USA 1997, 94:12354-12359.
23. Goldstein J.L., Rawson R.B., Brown M.S. Mutant mammalian cells as tools to delineate the sterol regulatory element-binding protein pathway for feedback regulation of lipid synthesis. Arch Biochem Biophys 2002, 397:139-148.
24. Horton J.D., Goldstein J.L., Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002, 109:1125-1131.
25. Amemiya-Kudo M., Shimano H., Hasty A.H., et al. Transcriptional activities of nuclear SREBP-1a, -1c, and -2 to different target promoters of lipogenic and cholesterogenic genes. J Lipid Res 2002, 43:1220-1235.
26. Smith J.R., Osborne T.F., Goldstein J.L., Brown M.S. Identification of nucleotides responsible for enhancer activity of sterol regulatory element in low density lipoprotein receptor gene. J Biol Chem 1999, 265:2306-2310.
27. Hirano Y., Yoshida M., Shimizu M., Sato R. Direct demonstration of rapid degradation of nuclear sterol regulatory element-binding proteins by the ubiquitin-proteasome pathway. J Biol Chem 2001, 276:36431-36437.
28. Vernia S., Eberlé D., Hernandez-Mijares A., Foufelle F., Casado M. A rare missense mutation in a type 2 diabetes patient decreases the transcriptional activity of human sterol regulatory element binding protein-1. Hum Mutat 2006, 27:212.
29. Hegarty B.D., Bobard A., Hainault I., Ferré P., Bossard P., Foufelle F. Distinct roles of insulin and liver X receptor in the induction and cleavage of sterol regulatory element-binding protein-1c. Proc Nat Acad Sci USA 2005, 102:791-796.
30. Llorente-Cortés V., Royo T., Otero-Viñas M., Berrozpe M., Badimon L. Sterol regulatory element binding proteins downregulate LDL receptor-related protein (LRP1) expression and LRP1-mediated aggregated LDL uptake by human macrophages. Cardiov Res 2007, 74:526-536.
31. Shimano H. Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog Lipid Res 2001, 40:439-452.
32. McPherson R., Gauthier A. Molecular regulation of SREBP function: the Insig-SCAP connection and isoform-specific modulation of lipid synthesis. Biochem Cell Biol 2004, 82:201-211.
33. Shimomura I., Bashmakov Y., Horton J.D. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 1999, 274:30028-30032.
34. Ferre P., Foufelle F. SREBP-1c transcription factor and lipid homeostasis: clinical perspective. Horm Res 2007, 68:72-82.
35. Toye A.A., Dumas M.E., Blancher C., et al. Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice. Diabetologia 2007, 50:1867-1879.
36. Bennett M.K., Osborne T.F. Selective association of sterol regulatory element-binding protein isoforms with target promoters in vivo. Proc Natl Acad Sci USA 2000, 97:6340-6344.
37. Bist A., Fielding P.E., Fielding C.J. Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol. Proc Natl Acad Sci. USA 1997, 94:10693.
38. Motoyama K., Fukumoto S., Koyama H., et al. SREBP inhibits VEGF expression in human smooth muscle cells. Biochem Biophys Res Commun 2006, 342:354-360.
39. Chakravarty K., Wu S.Y., Chiang C.M., Samols D., Hanson R.W., SREBP-1c Sp1 interact to regulate transcription of the gene for phosphoenolpyruvate carboxykinase (GTP) in the liver. J Biol Chem 2004, 279:15385-15395.
40. Gaëta B.A., Borthwick I., Stanley K.K. The 5'-flanking region of the alpha 2MR/LRP gene contains an enhancer-like cluster of Sp1 binding sites. Biochim Biophys Acta 1994, 1219:307-313.
41. Das A., Fernandez-Zapico M.E., Cão S., et al. Disruption of an SP2/KLF6 repression complex by SHP is required for farnesoid X receptor-induced endothelial cell migration. J Biol Chem 2006, 281:39105-39113.
42. Natesampillai S., Fernandez-Zapico M.E., Urrutia R., Veldhuis J.D. A novel functional interaction between the Sp1-like protein KLF13 and SREBP-Sp1 activation complex underlies regulation of low density lipoprotein receptor promoter function. J Biol Chem 2006, 281:3040-3047.
43. Cao S., Fernandez-Zapico M.E., Jin D., et al. KLF11-mediated repression antagonizes Sp1/sterol-responsive element-binding protein-induced transcriptional activation of caveolin-1 in response to cholesterol signaling. J Biol Chem 2005, 280:1901-1910.
44. Lomberk G., Urrutia R. The family feud: turning off Sp1-like KLF proteins. Biochem J 2005, 392:1-11.
45. Kaczynski J.A., Conley A.A., Fernandez Zapico M., Delgado S.M., Zhang J.S., Urrutia R. Functional analysis of basic transcription element (BTE)-binding protein (BTEB) 3 and BTEB4, a novel Sp1-like protein, reveals a subfamily of transcriptional repressors for the BTE site of the cytochrome P4501A1 gene promoter. Biochem J 2002, 366(Pt 3):873-882.